The Rapid Oral Fluid Screening Device Market is projected to grow with a CAGR of 6.8% over the forecast period. The growth rate of rapid oral fluid screening devices market can be attributed to the factor, such as growing alcohol & drug consumption. According to 2018, the National Survey on Drug Use and Health (NSDUH), 14.4 million adults aged 18 and older had an Alcohol Use Disorder (AUD) in the United States. With the increasing number of people addicted to alcohol and drugs, the need for the drug and alcohol testing increases, thereby creating sustained opportunities for manufacturers. Moreover, stringent regulations put into place for mandatory drug & alcohol testing, developing the use of rapid oral fluid screening devices by physician, independent, and hospital-based laboratories to perform the diagnostic procedures are also working in favor of the market growth.
Key Market Trends
Strips Segment is Dominating the Rapid Oral Fluid Screening Device Market.
The dominant share of the strips is due to the end-users opting for them over the swabs and cassettes due to the advantages of the strips. Easy portability with the minimum inconvenience involved makes strip a feasible option as compared to other forms of rapid oral fluid screening devices. In addition, strips are highly cost-effective as compared to swabs and cassettes, which is why many prefer using them. Apart from the advantages of the strips, the other set of factors boosting the growth of the segment is the increasing the need for screening drugs and alcohol, due to the increase in consumption and addiction. Workplace Testing is a major cohort using strip-based devices.
North America Dominates the Market and Expected to do Same in the Forecast Period
North America is expected to dominate the overall market, throughout the forecast period. The market growth is due to factors such as the high prevalence of drug abuse and tougher regulations and mandates for drug and alcohol testing by the government. According to National Institute on Drug Abuse, 21 to 29 percent of patients prescribed opioids for chronic pain misuse them, and in 2018, 46,802 Americans died as a result of an opioid overdose, including prescription opioids, heroin, and illicitly manufactured fentanyl, a powerful synthetic opioid. The Centers for Disease Control and Prevention estimates that the total financial load of prescription opioid misuse alone in the United States is USD 78.5 billion a year, including the costs of healthcare, lost efficiency, addiction treatment, and criminal justice involvement. Such statistics prove that there is an enormous need for the screening of drug abuse in-home care settings, roadside testing and as well as in workplaces. In such areas, the results should be on the spot and efficient which is why the rapid oral screening devices market is growing at a higher rate in this region.
The Rapid Oral Fluid Screening Device Market is moderately competitive with several major players. Some of the major companies leading the market are OraSure Technologies, Inc., Abbott Laboratories, Guangzhou Wondfo Biotech Co., Ltd, Oranoxis Inc., SCREEN ITALIA SRL, Securetec Detections-Systeme AG
Reasons to Purchase this report:
- The market estimate (ME) sheet in Excel format
- 3 months of analyst support